Breast cancer with negative expression of ER, PR and HER2 is called triple-negative breast cancer (TNBC), which is characterized by poor differentiation, high invasiveness, propensity for local and distant metastasis, poor prognosis, and high recurrence rate.1 This evidence concerns the gene ESR1 and breast carcinoma.